IN-DATE
CD1411-36Q: Abbott SJM ELLIPSE VR Tiered-Therapy ICD Cardioverter/Defibrillator
Sign in to add this product to your favorites!
| Price: | $4,999.00 per box of 1 |
|---|---|
| Quantity: | |
| In Stock: | 1 box of 1 |
| Status: | expired |
| Express: | Need it tomorrow? Order in next 2 hours 27 minutes and choose overnight shipping at checkout. |
Additional Details
Abbott Ellipse VR Single-Chamber Implantable Cardioverter Defibrillator
The Abbott Ellipse VR, REF CD1411-36Q, is a sterile, non-coated, single-chamber implantable cardioverter defibrillator designed to provide ventricular antitachycardia pacing and defibrillation for the automated treatment of life-threatening ventricular arrhythmias. Its compact, contoured pulse-generator design incorporates a DF4 connector for ventricular sensing, pacing and defibrillation. TailoredTherapy features support individualized therapy programming, while wireless connectivity enables remote device monitoring through the Merlin@home transmitter.
Product Code: CD1411-36Q
- Product type: Single-chamber implantable cardioverter defibrillator
- Abbreviation: VR ICD
- Therapy: Ventricular antitachycardia pacing and defibrillation
- Maximum delivered energy: 36 J
- Defibrillation connection: DF4
- Ventricular sensing and pacing connection: DF4
- Dimensions: 66 x 51 x 12 mm (2.60 x 2.01 x 0.47 inches)
- Volume: 30 cc
- Weight: 67 g (2.36 oz)
- Surface configuration: Non-coated
- Remote monitoring: Merlin@home transmitter
- MRI status: MR Conditional when used as part of a compatible system
- Usage: Sterile, implantable and single-use
AccessGUDID Info
- FDA Product Code: NVZ
- FDA Product Code Name: Pulse generator, permanent, implantable
- GMDN Term Code: 35852
- GMDN Term Name: Single-chamber implantable defibrillator
- GMDN Term Description: An implantable pulse generator (IPG) with a cardiac rhythm recognition system, to analyse an electrocardiogram (ECG), intended to deliver an electrical impulse(s) to defibrillate the heart (restore normal rhythm) or slow a rapid heart rate, and typically to pace a slow heart rate. It is implanted in a pouch beneath the skin of the patient's chest or abdomen and has connected a lead(s) that are positioned inside or on one heart chamber (typically right ventricle) to monitor the ECG and to automatically deliver the electrical impulse. It has internal batteries that provide the energy for the discharges; it is commonly known as an automatic implantable cardioverter-defibrillator (AICD).
Manufacturer
Abbott’s surgical innovations deliver advanced solutions that enhance precision, safety, and outcomes in the operating room. Building on the legacy of St. Jude Medical, Abbott offers a diverse portfolio of cutting-edge technologies, including structural heart devices like MitraClip™ for mitral valve repair and Amplatzer™ occluders for congenital heart defect closure. Their ProGlide™ vascular closure system and TactiCath™ ablation catheters further demonstrate Abbott’s commitment to empowering surgeons with reliable tools for minimally invasive procedures. By combining innovation with trusted expertise, Abbott continues to shape the future of surgical care. Browse Synergy Surgical's selection of Abbott surgical products, including Balloons, Stents, Vascular Closures and more.
